|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wadhwa R, Song S, Lee JS, Yao Y, Wei Q and
Ajani JA: Gastric cancer-molecular and clinical dimensions. Nat Rev
Clin Oncol. 10:643–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petroski MD and Deshaies RJ: Function and
regulation of cullin-RING ubiquitin ligases. Nat Rev Mol Cell Biol.
6:9–20. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi J, Lu G, Li L, Wang X, Cao L, Lin M,
Zhang S and Shao G: DNA damage-induced activation of CUL4B targets
HUWE1 for proteasomal degradation. Nucleic Acids Res. 43:4579–4590.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qian Y, Yuan J, Hu H, Yang Q, Li J, Zhang
S, Jiang B, Shao C and Gong Y: The CUL4B/AKT/β-catenin axis
restricts the accumulation of myeloid-derived suppressor cells to
prohibit the establishment of a tumor-permissive microenvironment.
Cancer Res. 75:5070–5083. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu Z, Li D, Xu H, Zhang R, Li B, Sun C,
Dong W and Zhang Y: CUL4B, NEDD4, and UGT1As involve in the TGF-β
signalling in hepatocellular carcinoma. Ann Hepatol. 15:568–576.
2016.PubMed/NCBI
|
|
7
|
Mok MT and Cheng AS: CUL4B: A novel
epigenetic driver in Wnt/β-catenin-dependent hepatocarcinogenesis.
J Pathol. 236:1–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang T, Tang HM, Wu ZH, Chen J, Lu S,
Zhou CZ, Yan DW and Peng ZH: Cullin 4B is a novel prognostic marker
that correlates with colon cancer progression and pathogenesis. Med
Oncol. 30:5342013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mao XW, Xiao JQ, Xu G, Li ZY, Wu HF, Li Y,
Zheng YC and Zhang N: CUL4B promotes bladder cancer metastasis and
induces epithelial-to-mesenchymal transition by activating the
Wnt/β-catenin signaling pathway. Oncotarget. 8:77241–77253. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mi J, Zou Y, Lin X, Lu J, Liu X, Zhao H,
Ye X, Hu H, Jiang B, Han B, et al: Dysregulation of the
miR-194-CUL4B negative feedback loop drives tumorigenesis in
non-small-cell lung carcinoma. Mol Oncol. 11:305–319. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu H, Yang Y, Ji Q, Zhao W, Jiang B, Liu
R, Yuan J, Liu Q, Li X, Zou Y, et al: CRL4B catalyzes H2AK119
monoubiquitination and coordinates with PRC2 to promote
tumorigenesis. Cancer Cell. 22:781–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Y, Liu R, Qiu R, Zheng Y, Huang W, Hu
H, Ji Q, He H, Shang Y, Gong Y, et al: CRL4B promotes tumorigenesis
by coordinating with SUV39H1/HP1/DNMT3A in DNA meth-ylation-based
epigenetic silencing. Oncogene. 34:104–118. 2015. View Article : Google Scholar
|
|
13
|
Yuan J, Han B, Hu H, Qian Y, Liu Z, Wei Z,
Liang X, Jiang B, Shao C and Gong Y: CUL4B activates Wnt/β-catenin
signalling in hepatocellular carcinoma by repressing Wnt
antagonists. J Pathol. 235:784–795. 2015. View Article : Google Scholar
|
|
14
|
Chen Z, Wang K, Hou C, Jiang K, Chen B,
Chen J, Lao L, Qian L, Zhong G, Liu Z, et al: CRL4BDCAF11 E3 ligase
targets p21 for degradation to control cell cycle progression in
human osteosarcoma cells. Sci Rep. 7:11752017. View Article : Google Scholar :
|
|
15
|
Qi M, Jiao M, Li X, Hu J, Wang L, Zou Y,
Zhao M, Zhang R, Liu H, Mi J, et al: CUL4B promotes gastric cancer
invasion and metastasis-involvement of upregulation of HER2.
Oncogene. 37:1075–1085. 2018. View Article : Google Scholar
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiang XJ, Deng J, Liu YW, Wan LY, Feng M,
Chen J and Xiong JP: MiR-1271 Inhibits Cell Proliferation, Invasion
and EMT in Gastric Cancer by Targeting FOXQ1. Cell Physiol Biochem.
36:1382–1394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia JT, Chen LZ, Jian WH, Wang KB, Yang
YZ, He WL, He YL, Chen D and Li W: MicroRNA-362 induces cell
proliferation and apoptosis resistance in gastric cancer by
activation of NF-κB signaling. J Transl Med. 12:332014. View Article : Google Scholar
|
|
21
|
Ma DH, Li BS, Liu JJ, Xiao YF, Yong X,
Wang SM, Wu YY, Zhu HB, Wang DX and Yang SM: miR-93-5p/IFNAR1 axis
promotes gastric cancer metastasis through activating the STAT3
signaling pathway. Cancer Lett. 408:23–32. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao Q, Liu F, Ji K, Liu N, He Y, Zhang W
and Wang L: MicroRNA-381 inhibits the metastasis of gastric cancer
by targeting TMEM16A expression. J Exp Clin Cancer Res. 36:292017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang B, Ji S, Ma F, Ma Q, Lu X and Chen
X: miR-489 acts as a tumor suppressor in human gastric cancer by
targeting PROX1. Am J Cancer Res. 6:2021–2030. 2016.PubMed/NCBI
|
|
24
|
Fang Z, Zhang L, Liao Q, Wang Y, Yu F,
Feng M, Xiang X and Xiong X: Regulation of TRIM24 by miR-511
modulates cell proliferation in gastric cancer. J Exp Clin Cancer
Res. 36:172017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
26
|
Han X, Fang Z, Wang H, Jiao R, Zhou J and
Fang N: CUL4A functions as an oncogene in ovarian cancer and is
directly regulated by miR-494. Biochem Biophys Res Commun.
480:675–681. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He X, Wei Y, Wang Y, Liu L, Wang W and Li
N: MiR-381 functions as a tumor suppressor in colorectal cancer by
targeting Twist1. Onco Targets Ther. 9:1231–1239. 2016.PubMed/NCBI
|
|
28
|
Yang X, Ruan H, Hu X, Cao A and Song L:
miR-381-3p suppresses the proliferation of oral squamous cell
carcinoma cells by directly targeting FGFR2. Am J Cancer Res.
7:913–922. 2017.PubMed/NCBI
|
|
29
|
Chen X, Wang YW, Xing AY, Xiang S, Shi DB,
Liu L, Li YX and Gao P: Suppression of SPIN1-mediated PI3K-Akt
pathway by miR-489 increases chemosensitivity in breast cancer. J
Pathol. 239:459–472. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He YM, Xiao YS, Wei L, Zhang JQ and Peng
CH: CUL4B promotes metastasis and proliferation in pancreatic
cancer cells by inducing epithelial-mesenchymal transition via the
Wnt/β-catenin signaling pathway. J Cell Biochem. 119:5308–5323.
2018. View Article : Google Scholar
|
|
31
|
Dong J, Wang XQ, Yao JJ, Li G and Li XG:
Decreased CUL4B expression inhibits malignant proliferation of
glioma in vitro and in vivo. Eur Rev Med Pharmacol Sci.
19:1013–1021. 2015.PubMed/NCBI
|
|
32
|
Chen Z, Shen BL, Fu QG, Wang F, Tang YX,
Hou CL and Chen L: CUL4B promotes proliferation and inhibits
apoptosis of human osteosarcoma cells. Oncol Rep. 32:2047–2053.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Q, Li Z, Wei S, Wang W, Chen Z, Zhang
L, Chen L, Li B, Sun G, Xu J, et al: Overexpression of miR-584-5p
inhibits proliferation and induces apoptosis by targeting WW
domain-containing E3 ubiquitin protein ligase 1 in gastric cancer.
J Exp Clin Cancer Res. 36:592017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie
G, Ma Y and Shen L: Exosomal transfer of tumor-associated
macrophage-derived miR-21 confers cisplatin resistance in gastric
cancer cells. J Exp Clin Cancer Res. 36:532017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Petersen B and Kingsley K: Differential
expression of miR-21, miR-133 and miR-155 from exosome fractions
isolated from oral squamous cell carcinomas in vitro. J Med Discov.
1:160102016.
|
|
36
|
Deng J, Lei W, Xiang X, Zhang L, Lei J,
Gong Y, Song M, Wang Y, Fang Z, Yu F, et al: Cullin 4A (CUL4A), a
direct target of miR-9 and miR-137, promotes gastric cancer
proliferation and invasion by regulating the Hippo signaling
pathway. Oncotarget. 7:10037–10050. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liang Y, Zhao Q, Fan L, Zhang Z, Tan B,
Liu Y and Li Y: Down-regulation of MicroRNA-381 promotes cell
proliferation and invasion in colon cancer through up-regulation of
LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ming J, Zhou Y, Du J, Fan S, Pan B, Wang
Y, Fan L and Jiang J: miR-381 suppresses C/EBPα-dependent Cx43
expression in breast cancer cells. Biosci Rep. 35:352015.
View Article : Google Scholar
|
|
39
|
Zhang Q, Zhao S, Pang X and Chi B:
MicroRNA-381 suppresses cell growth and invasion by targeting the
liver receptor homolog-1 in hepatocellular carcinoma. Oncol Rep.
35:1831–1840. 2016. View Article : Google Scholar
|
|
40
|
Tian C, Li J, Ren L, Peng R, Chen B and
Lin Y: MicroRNA-381 serves as a prognostic factor and inhibits
migration and invasion in non-small cell lung cancer by targeting
LRH-1. Oncol Rep. 38:3071–3077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang Z, Yang J, Xu G, Wang W, Liu C, Yang
H, Yu Z, Lei Q, Xiao L, Xiong J, et al: Targeting miR-381-NEFL axis
sensitizes glioblastoma cells to temozolomide by regulating
stemness factors and multidrug resistance factors. Oncotarget.
6:3147–3164. 2015.PubMed/NCBI
|
|
42
|
Li Y, Zhao C, Yu Z, Chen J, She X, Li P,
Liu C, Zhang Y, Feng J, Fu H, et al: Low expression of miR-381 is a
favorite prognosis factor and enhances the chemosensitivity of
osteosarcoma. Oncotarget. 7:68585–68596. 2016.PubMed/NCBI
|
|
43
|
Wang X, Wang X, Gu J, Zhou M, He Z, Wang X
and Ferrone S: Overexpression of miR-489 enhances efficacy of
5-fluorouracil-based treatment in breast cancer stem cells by
targeting XIAP. Oncotarget. 8:113837–113846. 2017. View Article : Google Scholar
|
|
44
|
Wu H, Xiao Z, Zhang H, Wang K, Liu W and
Hao Q: MiR-489 modulates cisplatin resistance in human ovarian
cancer cells by targeting Akt3. Anticancer Drugs. 25:799–809. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao S, Liu H, Hou S, Wu L, Yang Z, Shen J,
Zhou L, Zheng SS and Jiang B: MiR-489 suppresses tumor growth and
invasion by targeting HDAC7 in colorectal cancer. Clin Transl
Oncol. 20:703–712. 2018. View Article : Google Scholar
|
|
46
|
Xie Z, Cai L, Li R, Zheng J, Wu H, Yang X,
Li H and Wang Z: Down-regulation of miR-489 contributes into NSCLC
cell invasion through targeting SUZ12. Tumour Biol. 36:6497–6505.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang JQ, Chen S, Gu JN, Zhu Y, Zhan Q,
Cheng DF, Chen H, Deng XX, Shen BY and Peng CH: MicroRNA-300
promotes apoptosis and inhibits proliferation, migration, invasion
and epithelial-mesenchymal transition via the Wnt/β-catenin
signaling pathway by targeting CUL4B in pancreatic cancer cells. J
Cell Biochem. 119:1027–1040. 2018. View Article : Google Scholar
|
|
49
|
Chen B and Liu B: MiRNA-381 inhibits the
invasion of renal carcinoma and the underlying mechanisms. Zhong
Nan Da Xue Xue Bao Yi Xue Ban. 40:1053–1059. 2015.In Chinese.
PubMed/NCBI
|
|
50
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
